Type 2 inflammation is an underlying cause of nasal polyps in up to 80% of patients. Nasal polyps are predominantly characterized by type 2 inflammation of the nose and paranasal sinuses. DUPIXENT helps block two key sources of type 2 inflammation. This can result in shrinking of nasal polyps and reducing the need for surgery.